Meta-analisi: 1% di rimpianto dopo la chirurgia di genere, ma studi con follow-up brevi e forte attrito

Rimpianto dopo la chirurgia di affermazione di genere: revisione sistematica e meta-analisi della prevalenza

Authors
Valeria P. Bustos, Samyd S. Bustos, Andres Mascaro, Gabriel Del Corral, Antonio J. Forte, Pedro Ciudad, Esther A. Kim, Howard N. Langstein, Oscar J. Manrique
Journal
Plastic and Reconstructive Surgery Global Open
Year
2021

Summary

This review combined 27 studies of nearly 8,000 people who had gender surgery and estimated that about 1% regretted it. The authors concluded regret is extremely rare and credited better screening of patients. The 1% figure is now widely quoted. But the authors themselves say the evidence underneath is weak: most studies were rated poor or fair, almost none used tested ways of measuring regret, and results varied a lot between studies. Critics point out that people were often followed for only one or two years, while regret typically shows up after about eight years. Many people were lost track of (36% in the largest study), and some numbers were copied wrongly. Most people studied were adults treated under older, stricter rules. The 1% is best seen as a minimum drawn from incomplete data, not a reliable regret rate for today's patients.

Key findings

  • La revisione ha incluso 27 studi su 7.928 pazienti operati di 14 paesi; il 67% aveva subito chirurgia da maschio a femmina e il 33% da femmina a maschio, e solo un paziente era registrato come non binario.
  • Complessivamente, circa l'1% dei pazienti si è pentito dell'intervento (probabilmente tra meno dell'1% e il 2%), ma i risultati variavano molto tra gli studi; 77 persone in totale hanno riferito rimpianto.
  • Il rimpianto era inferiore all'1% dopo la chirurgia da femmina a maschio e l'asportazione del seno, 1% dopo la chirurgia da maschio a femmina e 2% dopo l'intervento per creare una vagina.
  • I motivi più comuni di rimpianto erano la difficoltà a essere accettati dalla famiglia e dalla società nel nuovo ruolo di genere, seguita da risultati chirurgici o fisici scarsi.
  • Quasi tutti gli studi usavano domande o interviste fatte in casa, la maggior parte era giudicata di qualità scarsa o discreta, e il follow-up andava da meno di 1 anno a 9 anni.
  • C'erano segnali che gli studi con basso rimpianto avessero più probabilità di essere pubblicati; correggere per questo ha abbassato la stima dall'1% allo 0,5%.
  • Una correzione del 2022 ha sistemato tabelle e figure dopo che gli autori hanno rifatto la revisione, e lettere pubblicate (Expósito-Campos & D'Angelo 2021; Bewley 2022) hanno contestato i metodi e le conclusioni.

Abstract

Background: There is an unknown percentage of transgender and gender non-confirming individuals who undergo gender-affirmation surgeries (GAS) that experiences regret. Regret could lead to physical and mental morbidity and questions the appropriateness of these procedures in selected patients. The aim of this study was to evaluate the prevalence of regret in transgender individuals who underwent GAS and evaluate associated factors.

Methods: A systematic review of several databases was conducted. Random-effects meta-analysis, meta-regression, and subgroup and sensitivity analyses were performed.

Results: A total of 27 studies, pooling 7928 transgender patients who underwent any type of GAS, were included. The pooled prevalence of regret after GAS was 1% (95% CI <1%-2%). Overall, 33% underwent transmasculine procedures and 67% transfemenine procedures. The prevalence of regret among patients undergoing transmasculine and transfemenine surgeries was <1% (IC <1%-<1%) and 1% (CI <1%-2%), respectively. A total of 77 patients regretted having had GAS. Twenty-eight had minor and 34 had major regret based on Pfäfflin's regret classification. The majority had clear regret based on Kuiper and Cohen-Kettenis classification.

Conclusions: Based on this review, there is an extremely low prevalence of regret in transgender patients after GAS. We believe this study corroborates the improvements made in regard to selection criteria for GAS. However, there is high subjectivity in the assessment of regret and lack of standardized questionnaires, which highlight the importance of developing validated questionnaires in this population.

Conclusion

Based on this review, there is an extremely low prevalence of regret in transgender patients after GAS. We believe this study corroborates the improvements made in regard to selection criteria for GAS. However, there is high subjectivity in the assessment of regret and lack of standardized questionnaires, which highlight the importance of developing validated questionnaires in this population.